NAVROGEN INC.

Profile

Company Names

NAVROGEN INC.
NAVROGEN, INC.
NAVROGEN, INC

Addresses

1837 UNIVERSITY CIRCLE, SCIENCE BUILDING RM 209, CHEYNEY, PA 19319

1837 UNIVERSITY CIR., SCIENCE CENTER ROOM 218, CHEYNEY, PA 19319

5600 CITY AVE., SCIENCE CENTER, ROOM 108A, PHILADELPHIA, PA 19131

ST JOSEPH UNIVERSITY, 5600 CITY AVE., SCIENCE CENTER, ROOM 206, PHILADELPHIA, PA 19131

Phone Numbers

6103992717
484-802-3135
610.660.1931
6106601931

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$12,801,161.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-06-05 
$542,000.00 
$1,000,000.00 
$458,000.00 
 
2
2021-07-29 
$9,059,161.00 
$9,258,328.00 
$199,167.00 
Equity 
1
2018-10-10 
$3,200,000.00 
$3,200,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLAN 
 
BEDWICK 
DIRECTOR
AVISA PHARMA INC.   |  GUARD MACRO OFFSHORE FEEDER FUND   |  GUARD MACRO US FEEDER FUND   |  NAVROGEN, INC.   |  L+R ASIA CREDIT ALPHA FUND   |  NAVROGEN INC.
LUIGI 
 
GRASSO 
EXECUTIVE OFFICER, DIRECTOR
NAVROGEN, INC   |  NAVROGEN, INC.   |  NAVROGEN INC.
STEVEN 
G 
KYRIAKOS 
EXECUTIVE OFFICER
NAVROGEN, INC
LEON 
O 
MOULDER, JR 
DIRECTOR
NAVROGEN INC.
LEON 
O. 
MOULDER, JR. 
DIRECTOR
TESARO, INC.   |  INTERIUS BIOTHERAPEUTICS, INC.   |  DIANTHUS THERAPEUTICS, INC.   |  NAVROGEN, INC.   |  PRAEVENTIX, INC.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  NAVROGEN INC.   |  ZENAS BIOPHARMA, INC.
NICHOLAS 
 
NICOLAIDES 
EXECUTIVE OFFICER, DIRECTOR
NAVROGEN, INC
NICHOLAS 
C. 
NICOLAIDES 
EXECUTIVE OFFICER, DIRECTOR
NAVROGEN, INC.   |  NAVROGEN INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-06-05 
2024-06-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-06-05 
2023-02-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-29 
2021-08-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-29 
2019-09-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2018-10-10 
2018-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2018-10-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NA
NONE